PZPaula Daniela Nieto Zambrano

Paula Daniela Nieto Zambrano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paula Daniela Nieto Zambrano has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of lymphocyte populations, cytokine, and autoantibody profile in patients with rheumatoid arthritis: a study of cases with COVID-19 and controls without COVID-19

    by Julián Arias-Aponte, Gabriel E Acelas-Gonzalez, Rafael Parra-Medina, María L Monsalve-Córdoba, Adriana Rojas-Villarraga, Paula D Nieto-Zambrano, Maria C Cortés-Osma, Hector F Restrepo-Guerrero, Laura Villarreal, Pedro Santos-Moreno, et al.

    Introduction: The SARS-CoV-2 pandemic is associated with the development of acute respiratory distress syndrome (ARDS) and post-COVID syndrome (PCS). PSC has been linked to autoimmune diseases, including rheumatoid arthritis (RA), a condition characterized by chronic joint pain driven by dysregulated immune response. This study aims to evaluate the impact of SARS-CoV-2 infection on patients with RA. Methods: A total of 300 RA patients were included in the study, categorized into two groups: patients with a history of SARS-CoV-2 infection (n = 148) and without prior COVID-19 infection (control group; n = 152). Demographic information, comorbidities, treatments, autoantibodies, cell populations, and cytokines were assessed. Results: A majority of the patients included in this study were female. A high percentage of patients completed the COVID-19 vaccination schedule. The mean age at RA diagnosis was 44.71 years, with most patients presenting with low disease activity. Patients with a history of SARS-CoV-2 infection reported headache, cough, and fatigue more often. A proportion of these symptoms persisted beyond 12 weeks, consistent with PCS. Autoantibody analysis revealed a high seropositivity rate in both groups, with no statistically significant differences related to SARS-CoV-2 infection. Similarly, the evaluation of immune system cell populations showed no significant variations between groups. Cytokine level analysis also demonstrated no statistically significant differences between cases and controls. However, IL-6 data were unavailable for 37% of participants. Conclusions: Long-term follow-up did not demonstrate statistically significant alterations in the immunological profile of RA patients with SARS-CoV-2 infection. Nevertheless, further prospective studies are required to elucidate potential long-term immunological effects in this population.

  • Open Access

    Hipercalcemia asociada a hiperparatiroidismo primario: enfoque y manejo a partir de un caso clínico

    by Rodolfo Torres, Carlos Rosselli, Maricely Reina, Carlos Madariaga, David Hamon-Rugeles, Edwin Núñez, Paula Nieto-Zambrano

    Background: Calcium is the most abundant electrolyte in the human body, hypercalcemia is a common disorder usually caused by primary hyperparathyroidism or malignancy. A proportion of cases presenting as an emergency, leading to significant mortality. The management of hypercalcemia depends on the presentation and underlying cause. Purpose: to present an unusual case of clinical presentation of hypercalcemia associated with primary hyperparathyroidism, as well as to give a brief review about the approach and management of this pathology. Case presentation: A 32-year-old female patient, with a history of unresected parathyroid adenoma and pancreatitis, attended for 3 days of abdominal pain, moderate intensity, accompanied by emetic episodes of food content, initial paraclinical findings showed severe hypercalcemia, electrocardiogram with block grade I atrioventricular, arterial gases with acute respiratory alkalosis and hyperlactatemia. CT of the abdomen with brown tumors. She was admitted to the ICU for administration of intravenous fluids, loop diuretics, and cinacalcet without showing any improvement, so hemodialysis therapy was indicated. Discussion and conclusion: hypercalcemia is a frequent finding. Primary hyperparathyroidism and malignancy are the two most common causes of elevated serum calcium levels, together accounting for about 90% of all cases. Serum values vary between total calcium 8.5 and 10.5 mg/dl and ionic 1.16-1.31. Serum Ca 2+ concentration is closely related by the actions of parathyroid hormone and calcitriol. Primary hyperparathyroidism occurs as a result of adenomas, hyperplasias, or carcinoma. The clinical manifestations and severity will be correlated with the duration of the disease, calcium and PTH levels. Within the treatment, this will be guided by its cause, however, it is possible to classify it into urgent and non-urgent treatment. The approach to severe acute hypercalcemia is a diagnostic challenge given the multiple causes that can lead to this hydroelectrolyte disorder and the rapid establishment of treatment that is required when it is detected. Introducción: el calcio es el electrolito más abundante del cuerpo humano y la hipercalcemia es el trastorno común causado normalmente por el hiperparatiroidismo primario o malignidad, su manejo depende de la presentación y causa subyacente. Además, una proporción de casos se presentan como una emergencia, lo que conlleva a una mortalidad significativa. Objetivo: mostrar un caso inusual de presentación clínica de hipercalcemia asociada a hiperparatiroidismo primario y, asimismo, dar una breve revisión acerca del enfoque y el manejo de esta patología. Presentación del caso: paciente femenina de 32 años, antecedente de adenoma paratiroideo no resecado y pancreatitis, asiste por tres días de dolor abdominal de tipo cólico y de moderada intensidad, acompañado de episodios eméticos de contenido alimentario, paraclínicos iniciales con hipercalcemia severa, electrocardiograma con bloqueo auriculoventricular grado I, gases arteriales con alcalosis respiratoria aguda e hiperlactatemia. También se le practicó un TAC de abdomen donde este apareció con tumores pardos. Se ingreso? a la UCI para la administración de líquidos endovenosos, diuréticos de asa y cinacalcet, pero no presentó mejoría, por lo que se indicó terapia de hemodiálisis. Discusión y conclusión: la hipercalcemia es un hallazgo frecuente. El hiperparatiroidismo primario y la neoplasia maligna son las dos causas más frecuentes de aumento de los niveles de calcio sérico y, en conjunto, representan alrededor del 90?% de todos los casos, donde los valores en suero varían entre el calcio total (8,5 y 10,5 mg/dl) y el iónico (1,16-1,31). La concentración sérica de Ca 2+ esta? estrechamente relacionada por las acciones de la hormona paratiroidea y el calcitriol, donde el hiperparatiroidismo primario ocurre como resultado de adenomas, hiperplasias y carcinoma. Las manifestaciones clínicas y la severidad van a estar correlacionadas con el tiempo de duración de la enfermedad, los niveles de calcio y de PTH. Dentro del tratamiento, este será guiado por su causa, sin embargo, es posible clasificarlo en tratamiento urgente y no urgente. Además, el enfoque de la hipercalcemia aguda severa es un reto diagnóstico dadas las múltiples causas que pueden llevar a este trastorno hidroelectrolítico y la rápida instauración de tratamiento que se requiere cuando es detectada.

  • Open Access

    Polyautoimmunity in systemic lupus erythematosus patients: New insights from a cross-sectional study

    by Pedro Santos-Moreno, Julián Arias-Aponte, Gabriel-Santiago Rodríguez-Vargas, Paula Daniela Nieto-Zambrano, Laura Villarreal, Linda Ibatá, Susan Martinez, Jaime-Andrés Rubio-Rubio, Pedro Rodríguez, Adriana Rojas-Villarraga


  • Open Access

    Análisis clínico e histopatológico de la prevalencia de enfermedades cardiacas en muerte súbita. Estudio en autopsias

    by Juan Carlos Bonilla Jassir, Rafael Parra Medina, José Fernando Polo Nieto, Juan Eduardo Rocha Aguirre, Juan Pablo Téllez Rodríguez, Juan José Cháves, Paula Daniela Nieto, Oscar Campuzano Larrea, Georgia Sarquella Brugada, Josep Brugada, et al.

    Introduction: a sudden death incident has a great impact on society and its study is important to provide understanding for strengthening promotion and prevention strategies. Objective: to determine the prevalence of definitive anatomopathological cardiac diagnoses and histopathological findings associated with sudden death due to a cardiovascular cause based on autopsies performed at Hospital de San José in Bogotá DC, Colombia, during the period between 2015 and 2018. Methods: retrospective descriptive cross-sectional study of cases of sudden cardiac death of cardiovascular origin diagnosed in autopsies performed at the pathology service of Hospital de San José, Bogotá DC, Colombia. Results: 178 autopsies with a diagnosis of sudden cardiac death were included. The overall mean age was 56.1 years (SD: 15.06). Male/female ratio was 3:1. The most frequent macroscopic finding was cardiomegaly (average 428.1 g (SD 112.8), with the presence of sclerotic coronary artery disease (p=0.000) with a blockage greater than 80% (p=0.037) in the major coronary arteries. Conclusions: the prevalent definitive anatomopathological diagnoses in SCD were complicated chronic ischemic heart disease (65%) and acute myocardial infarction (16%). Data obtained in this study is similar to that reported worldwide. Cardiomegaly is a frequent finding that should be carefully evaluated.


  • Open Access

    Asociación del grupo sanguíneo ABO con complicaciones en covid-19 : revisión sistemática y meta-análisis.

    by Paula Daniela Nieto Zambrano, Hector Fabio Restrepo, John Jaime Sprockel, María Lorcy Monsalve Córdoba, Arley Gómez López

    Introduction: ABO blood groups have been used as outcome predictor in different diseases; granting a protective factor for individuals with O blood group and a risk factor the ones with A blood group. During the SARS CoV-1 outbreak, was proposed the existence of a possible relationship between the risk of infection and the type of ABO group; it is expected that in COVID-19 pandemic could exist the same situation among determined outcomes and ABO groups. The aim is to determine the association among different blood groups and mortality, intensive care unit (ICU) requirement, and orotracheal intubation in COVID-19 infected population. Material and Methods: a systematic review and meta-analysis was performed between January 2020 and March 2021, from MEDLINE, EMBASE, SCOPUS, Latindex and LILACS databases; that included the mentioned outcomes in COVID 19 population. Results: 16 studies were included in which mainly were retrospective and multicentric. Patients with A blood group have an increased risk of mortality compared with the rest of the groups (OR 1.08 CI95% 1.01-0.17); for intensive care unit (ICU) requirement it did not showed statistically significant difference between groups. Finally it was observed that AB blood group represents a risk factor for orotracheal intubation outcome (OR 1.42 CI95% 1.02-1.96), meanwhile group A demonstrated protection against it (OR 0.84 CI95% 0.73-0.97). Conclusions: it is prove the relationship between blood groups and outcomes related to SARS CoV-2 infection. There are needed prospective studies that evaluate blood group, Rh, and specific outcomes.